-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Interpace Biosciences, Inc. quarterly/annual Revenues history and growth rate from Q2 2011 to Q4 2022.
- Interpace Biosciences, Inc. Revenues for the quarter ending December 31, 2022 was $1K.
- Interpace Biosciences, Inc. Revenues for the twelve months ending December 31, 2022 was $5.68M.
- Interpace Biosciences, Inc. annual Revenues for 2022 was $5.68M, a 30.7% decline from 2021.
- Interpace Biosciences, Inc. annual Revenues for 2021 was $8.2M.
- Interpace Biosciences, Inc. annual Revenues for 2018 was $21.9M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)